|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 473/18 | (2006.01) |
| A61K 31/522 | (2006.01) | ||
| C07D 519/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3558997 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17825829.9 |
| Date of filing the European patent application | 2017-12-19 | |
| (97) | Date of publication of the European application | 2019-10-30 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-27 |
| (46) | Date of publication of the claims translation | 2021-04-26 |
| (86) | Number | PCT/EP2017/083625 |
| Date | 2017-12-19 |
| (87) | Number | WO 2018/114999 |
| Date | 2018-06-28 |
| (30) | Number | Date | Country code |
| 201662436619 P | 2016-12-20 | US |
| (72) |
FINLAY, Maurice, Raymond, Verschoyle, GB
GOLDBERG, Frederick, Woolf, GB
TING, Attilla, Kuan, Tsuei, GB
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Aminotriazolopiridino junginiai ir jų naudojimas vėžio gydymui |
| AMINO-TRIAZOLOPYRIDINE COMPOUNDS AND THEIR USE IN TREATING CANCER |
| Payment date | Validity (years) | Amount | |
| 2024-11-22 | 8 | 185.00 EUR |
| 2025-12-19 |